Form 4 for RMD ResMed|
Accepted 2024-08-13 00:00:00 ET · period of report 2024-08-12 · accession 0001127602-24-022064 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-08-13 | 2024-08-12 | RMD | Ghoshal Kaushik | Pres, SaaS Business | M - OptEx | $96.41 | +10.0K | 23.0K | +77% | +$964.1K |
| D | 2024-08-13 | 2024-08-12 | RMD | Ghoshal Kaushik | Pres, SaaS Business | S - Sale+OE | $216.60 | -10.0K | 13.0K | -43% | -$2.17M |
| DM | 2024-08-13 | 2024-08-12 | RMD | Ghoshal Kaushik | Pres, SaaS Business | M - OptEx | $0.00 | -10.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | ResMed Common Stock | 2024-08-12 | M | A | 6,877 | $95.80 | 21,995 | D | — | — | |
| 2 | Common | ResMed Common Stock | 2024-08-12 | M | A | 2,086 | $95.80 | 15,118 | D | — | — | |
| 3 | Common | ResMed Common Stock | 2024-08-12 | S | D | 10,000 | $216.60 | 13,032 | D | — | — | |
| 4 | Common | ResMed Common Stock | 2024-08-12 | M | A | 1,037 | $101.64 | 23,032 | D | — | — | |
| 5 | Derivative | ResMed Common Stock Options | 2024-08-12 | M | D | 2,086 | $0.00 | 0 | D | $95.80 · 2018-04-02 to 2025-04-02 | 2,086 ResMed Common Stock | (F2) Represents date options first became exercisable. Options vest 1/3 per year. |
| 6 | Derivative | ResMed Common Stock Options | 2024-08-12 | M | D | 1,037 | $0.00 | 9,260 | D | $101.64 · 2018-11-14 to 2025-11-14 | 1,037 ResMed Common Stock | |
| 7 | Derivative | ResMed Common Stock Options | 2024-08-12 | M | D | 6,877 | $0.00 | 0 | D | $95.80 · 2018-04-02 to 2025-04-02 | 6,877 ResMed Common Stock |